Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Earnings Yield Over TimeElevated
Percentile Rank79
3Y CAGR+14.8%
5Y CAGR+12.1%
Studio
Year-over-Year Change

Earnings yield ratio

3Y CAGR
+14.8%/yr
Annual compound
5Y CAGR
+12.1%/yr
Consistent
Percentile
P79
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20253.93%-46.4%
20247.32%+26.8%
20235.78%+122.5%
20222.60%-63.5%
20217.12%+220.9%
20202.22%+178.6%
2019-2.82%+26.2%
2018-3.83%-268.0%
20172.28%+127.8%
2016-8.20%-